← Back to Search

BOOM-IBD2 Pivotal Clinical Trial

N/A
Waitlist Available
Research Sponsored by Boomerang Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

The BOOM-IBD2 clinical trial is designed to evaluate the effectiveness of sacral neuromodulation for the treatment of signs and symptoms of ulcerative colitis.

Eligible Conditions
  • Inflammatory Bowel Disease
  • Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bowel Urgency

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
Patients implanted with neuromodulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neuromodulation
2022
Completed Phase 4
~70

Find a Location

Who is running the clinical trial?

Boomerang MedicalLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
~91 spots leftby Feb 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top